• No results found

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)

N/A
N/A
Protected

Academic year: 2020

Share "The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)"

Copied!
31
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Table 1 Key clinical immunotherapy recommendations for treatment of patients with HNC
Table 1 Key clinical immunotherapy recommendations for treatment of patients with HNC (Continued)
Fig. 1 Treatment Algorithm 1: First-line treatment for R/M HNSCC patients. Immunotherapy treatment algorithm for R/M Systemic Therapy NaïveHNSCC
Fig. 2 Treatment Algorithm 2: Second-line treatment for R/M HNSCC patients. Immunotherapy treatment algorithm for platinum-refractory recurrent/metastaticHNSCC based on current FDA approvals for pembrolizumab and nivolumab as second-line therapies
+6

References

Related documents

Using this approach, Phillips and Bana e Costa (2007) combine simple preference modelling with communication-enhancing decision conferencing (Phillips, 2006) for an

In the present study significant differences in transfusion dependency was observed indicating that Xmn1 positive patients were statistically less transfusion

Here it could be seen that nature – the sands, the wind, and the sun – as spirit has helped Santiago in his process to realize his real happiness, finding his hidden treasure,

Kremastinos reported that NT-Pro BNP was increased in major beta thalassemia patients compared to controls and this increase in patients was likely due to age and

To address the functionality of the RNAi mechanism in this species, dsRNA was injected into second in- star larvae targeting laccase2 , a gene which encodes an enzyme involved in

The primary goal of the present study was to investigate the correlation between self-reported alcohol consumption, using the AUDIT-C, and a direct biomarker for alcohol con-

[r]